TY - JOUR
T1 - Multimorbidity Burden and Adverse Outcomes in a Community-Based Cohort of Adults with Heart Failure
AU - Tisminetzky, Mayra
AU - Gurwitz, Jerry H.
AU - Fan, Dongjie
AU - Reynolds, Kristi
AU - Smith, David H.
AU - Magid, David J.
AU - Sung, Sue Hee
AU - Murphy, Terrence E.
AU - Goldberg, Robert J.
AU - Go, Alan S.
N1 - Funding Information:
Conflicts of Interest: Dr. Go reports receiving grant funding through his institution (Kaiser Permanente Northern California Division of Research) from Astra-Zeneca, Novartis, and GlaxoSmithKline, as well as from the National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging (NIA); and the Patient-Centered Outcomes Research Institute. Dr. Smith reports receiving grant funding through his institution (Center for Health Research, Kaiser Perma-nente Northwest) from Novartis to undertake a Food and Drug Administration–mandated drug safety study. Dr. Reynolds reports receiving grant funding through her institution (Department of Research & Evaluation, Kaiser Permanente Southern California) from Novartis. The other authors report no conflicts.
Funding Information:
Conflicts of Interest: Dr. Go reports receiving grant funding through his institution (Kaiser Permanente Northern California Division of Research) from Astra-Zeneca, Novartis, and GlaxoSmithKline, as well as from the National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging (NIA); and the Patient-Centered Outcomes Research Institute. Dr. Smith reports receiving grant funding through his institution (Center for Health Research, Kaiser Permanente Northwest) from Novartis to undertake a Food and Drug Administration?mandated drug safety study. Dr. Reynolds reports receiving grant funding through her institution (Department of Research & Evaluation, Kaiser Permanente Southern California) from Novartis. The other authors report no conflicts. Study concept and design: MT, JHG, ASG. Acquisition of data: JHG, GT, KR, DHS, DJM, ASG. Analysis and interpretation of data: MT, JHG, GT, KR, DHS, DJM, SHS, RG, TEM, ASG. Preparation of manuscript: MT, GT, ASG. Critical revision of manuscript: JHG, KR, DHS, DJM, JHS, RG, TEM. Sponsor's Role: The NIA and the National Institutes of Health had no role in the preparation, review, or approval of the manuscript, or decision to submit the manuscript for publication.
Publisher Copyright:
© 2018, Copyright the Authors Journal compilation © 2018, The American Geriatrics Society
PY - 2018/12
Y1 - 2018/12
N2 - OBJECTIVES: To assess multimorbidity burden and its association with clinical outcomes in adults with heart failure (HF) according to sex, age, and HF type. DESIGN: Retrospective cohort study. SETTING: Five healthcare delivery systems across the United States. PARTICIPANTS: Adults with HF (N=114,553). MEASUREMENTS: We characterized participants with respect to the presence of 26 chronic conditions categorized into quartiles based on overall burden of comorbidity (<5, 5–6, 7–8, ≥9). Outcomes included all-cause death and hospitalization for HF or any cause. Multivariable Cox regression was used to evaluate the adjusted association between categorized burden of multimorbidity burden and outcomes. RESULTS: Individuals with more morbidities were more likely to die than those with fewer then 5 morbidities (5–6 morbidities: adjusted hazard ratio (aHR)=1.27 (95% confidence interval (CI)=1.24–1.31; 7–8 morbidities: aHR=1.52, 95% CI=1.48–1.57; ≥9 morbidities: aHR=1.92, 95% CI=1.86–1.99). There was a graded, higher adjusted rate of any-cause hospitalization associated with 5 or 6 (aHR=1.28, 95% CI=1.25–1.30), 7 or 8 (aHR=1.47, 95% CI=1.44–1.50), or 9 or more (aHR=1.77, 95% CI=1.73–1.82) morbidities (vs <5). Similar findings were observed for HF-specific hospitalization in those with 5 or 6 (aHR=1.22, 95% CI=1.19–1.26), 7 or 8 (aHR=1.39, 95% CI=1.34–1.44), or 9 or more (aHR 1.68, 95% CI=1.61–1.74) morbidities (vs <5). Consistent findings were seen according to sex, age group, and HF type (preserved, reduced, borderline HF), in the association between categorical burden of multimorbidity and outcomes especially prominent in individuals younger than 65. CONCLUSION: After adjustment, higher levels of multimorbidity predicted worse HF outcomes and may be an important consideration in strategies to improve clinical and person-centered outcomes. J Am Geriatr Soc 66:2305–2313, 2018.
AB - OBJECTIVES: To assess multimorbidity burden and its association with clinical outcomes in adults with heart failure (HF) according to sex, age, and HF type. DESIGN: Retrospective cohort study. SETTING: Five healthcare delivery systems across the United States. PARTICIPANTS: Adults with HF (N=114,553). MEASUREMENTS: We characterized participants with respect to the presence of 26 chronic conditions categorized into quartiles based on overall burden of comorbidity (<5, 5–6, 7–8, ≥9). Outcomes included all-cause death and hospitalization for HF or any cause. Multivariable Cox regression was used to evaluate the adjusted association between categorized burden of multimorbidity burden and outcomes. RESULTS: Individuals with more morbidities were more likely to die than those with fewer then 5 morbidities (5–6 morbidities: adjusted hazard ratio (aHR)=1.27 (95% confidence interval (CI)=1.24–1.31; 7–8 morbidities: aHR=1.52, 95% CI=1.48–1.57; ≥9 morbidities: aHR=1.92, 95% CI=1.86–1.99). There was a graded, higher adjusted rate of any-cause hospitalization associated with 5 or 6 (aHR=1.28, 95% CI=1.25–1.30), 7 or 8 (aHR=1.47, 95% CI=1.44–1.50), or 9 or more (aHR=1.77, 95% CI=1.73–1.82) morbidities (vs <5). Similar findings were observed for HF-specific hospitalization in those with 5 or 6 (aHR=1.22, 95% CI=1.19–1.26), 7 or 8 (aHR=1.39, 95% CI=1.34–1.44), or 9 or more (aHR 1.68, 95% CI=1.61–1.74) morbidities (vs <5). Consistent findings were seen according to sex, age group, and HF type (preserved, reduced, borderline HF), in the association between categorical burden of multimorbidity and outcomes especially prominent in individuals younger than 65. CONCLUSION: After adjustment, higher levels of multimorbidity predicted worse HF outcomes and may be an important consideration in strategies to improve clinical and person-centered outcomes. J Am Geriatr Soc 66:2305–2313, 2018.
UR - http://www.scopus.com/inward/record.url?scp=85053858725&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053858725&partnerID=8YFLogxK
U2 - 10.1111/jgs.15590
DO - 10.1111/jgs.15590
M3 - Article
C2 - 30246862
AN - SCOPUS:85053858725
SN - 0002-8614
VL - 66
SP - 2305
EP - 2313
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
IS - 12
ER -